Nitric oxide and cardiac function

Life Sciences

Volumn 81, Issue 10, 2007, Pages 779-793

  Rastaldo, R ^a   Pagliaro, P ^a   Cappello, S ^a   Penna, C ^a   Mancardi, D ^a   Westerhof, N ^b   Losano, G ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac remodeling; Cyclic GMP; Myocardial contractility; Nitric oxide; Postconditioning; Preconditioning

Indexed keywords

CALCIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHODIESTERASE III;

ADRENERGIC STIMULATION; BLOOD PRESSURE; ENZYME INHIBITION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; HEART RATE; HEART VENTRICLE REMODELING; NONHUMAN; PRESSORECEPTOR; REVIEW; VASODILATATION;

ANIMALS; DISEASE MODELS, ANIMAL; HEART; HEART RATE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL CONTRACTION; NITRIC OXIDE; REPERFUSION INJURY; VENTRICULAR REMODELING;

EID: 34548247143     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.07.019     Document Type: Review

References (143)

1. Adak S., Wang Q., and Stuehr D.J. Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism. Journal of Biological Chemistry 275 43 (2000) 33554-33561
2. Altman J.D., Kinn J., Duncker D.J., and Bache R.J. Effect of inhibition of nitric oxide formation on coronary blood flow during exercise in the dog. Cardiovascular Research 28 1 (1994) 119-124
3. Balligand J.L., Kelly R.A., Marsden P.A., Smith T.W., and Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proceedings of the National Academy of Sciences of the United States of America 90 1 (1993) 347-351
4. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., and Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences of the United States of America 87 4 (1990) 1620-1624
5. Bernardi P., and Petronilli V. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. Journal of Bioenergetics and Biomembranes 28 2 (1996) 131-138
6. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. Journal of Molecular and Cellular Cardiology 33 11 (2001) 1897-1918
7. Bolli R., Dawn B., Tang X.L., Qiu Y., Ping P., Xuan Y.T., Jones W.K., Takano H., Guo Y., and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Research in Cardiology 93 5 (1998) 325-338
8. Bolli R., Dawn B., and Xuan Y.T. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends in Cardiovascular Medicine 13 2 (2003) 72-79
9. Brady A.J., Warren J.B., Poole-Wilson P.A., Williams T.J., and Harding S.E. Nitric oxide attenuates cardiac myocyte contraction. American Journal of Physiology 256 1Pt2 (1993) H176-H182
10. Broillet M.C. S-nitrosylation of proteins. Cellular and Molecular Life Sciences 55 8-9 (1999) 1036-1042
11. Bronzwaer J.G., Zeitz C., Visser C.A., and Paulus W.J. Endomyocardial nitric oxide synthase and the hemodynamic phenotypes of human dilated cardiomyopathy and of athlete's heart. Cardiovascular Research 55 2 (2002) 270-278 (discussion 225-278)
12. Brutsaert D.L. Cardiac endothelial-myocardial signaling: its role in cardiac growth, contractile performance, and rhythmicity. Physiological Reviews 83 1 (2003) 59-115
13. Brutsaert D.L., Fransen P., Andries L.J., De Keulenaer G.W., and Sys S.U. Cardiac endothelium and myocardial function. Cardiovascular Research 38 (1998) 281-290
14. Casadei B., and Sears C.E. Nitric-oxide-mediated regulation of cardiac contractility and stretch responses. Progress in Biophysics and Molecular Biology 82 1-3 (2003) 67-80
15. Cerra M.C., and Pellegrino D. Cardiovascular cGMP-generating systems in physiological and pathological conditions. Current Medical Chemistry 14 5 (2007) 585-599
16. Champion H.C., Georgakopoulos D., Takimoto E., Isoda T., Wang Y., and Kass D.A. Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circulation Research 94 5 (2004) 657-663
17. Chen Y., Traverse J.H., Du R., Hou M., and Bache R.J. Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106 2 (2002) 273-279
18. Chotani M.A., Mitra S., Eid A.H., Han S.A., and Flavahan N.A. Distinct cAMP signaling pathways differentially regulate alpha2C-adrenoceptor expression: role in serum induction in human arteriolar smooth muscle cells. American Journal of Physiology. Heart and Circulatory Physiology 288 1 (2005) H69-H76
19. Cohen R.A., and Vanhoutte P.M. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation 92 11 (1995) 3337-3349
20. Crystal G.J., Zhou X., Gurevicius J., and Ramez Salem M. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts. Anesthesia & Analgesia 87 5 (1998) 994-1001
21. Dawson D., Lygate C.A., Zhang M.H., Hulbert K., Neubauer S., and Casadei B. nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction. Circulation 112 24 (2005) 3729-3737
22. Di Lisa F., Menabo R., Canton M., Barile M., and Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. Journal of Biological Chemistry 276 4 (2001) 2571-2575
23. Downey J.M., and Cohen M.V. Signal transduction in ischemic preconditioning. Advances in Experimental Medicine and Biology 430 (1997) 39-55
24. Ekelund U.E., Harrison R.W., Shokek O., Thakkar R.N., Tunin R.S., Senzaki H., Kass D.A., Marban E., and Hare J.M. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circulation Research 85 5 (1999) 437-445
25. Feelisch M., and Stamler J.S. Donors of nitrogen oxides. In: Feelisch M., and Stamler J.S. (Eds). Methods in nitric oxide Research (1996), Wiley, New York 71-115
26. Feletou M., and Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. British Journal of Pharmacology 93 3 (1988) 515-524
27. Fellet A.L., Di Verniero C., Arza P., Tomat A., Varela A., Arranz C., and Balaszczuk A.M. Effect of acute nitric oxide synthase inhibition in the modulation of heart rate in rats. Brazilian Journal of Medical and Biological Research 36 5 (2003) 669-676
28. Fellet A.L., Arza P., Arreche N., Arranz C., and Balaszczuk A.M. Nitric oxide and thyroid gland: modulation of cardiovascular function in autonomic-blocked anaesthetized rats. Experimental Physiology 89 3 (2004) 303-312
29. Ferreira-Melo S.E., Yugar-Toledo J.C., Coelho O.R., De Luca I.M., Tanus-Santos J.E., Hyslop S., Irigoyen M.C., and Moreno Jr. H. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats. European Journal of Pharmacology 542 1-3 (2006) 141-147
30. Fukuto J.M., Chiang K., Hszieh R., Wong P., and Chaudhuri G. The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor. Journal of Pharmacology and Experimental Therapeutics 263 2 (1992) 546-551
31. Gallo M.P., Ghigo D., Bosia A., Alloatti G., Costamagna C., Penna C., and Levi R.C. Modulation of guinea-pig cardiac L-type calcium current by nitric oxide synthase inhibitors. Journal of Physiology 506 Pt 3 (1998) 639-651
32. Godecke A., Heinicke T., Kamkin A., Kiseleva I., Strasser R.H., Decking U.K., Stumpe T., Isenberg G., and Schrader J. Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts. Journal of Physiology 532 Pt 1 (2001) 195-204
33. Graser T., and Vanhoutte P.M. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. American Journal of Physiology 261 6 Pt 2 (1991) H1769-H1777
34. Gyurko R., Kuhlencordt P., Fishman M.C., and Huang P.L. Modulation of mouse cardiac function in vivo by eNOS and ANP. American Journal of Physiology. Heart and Circulatory Physiology 278 3 (2000) H971-H981
35. Halestrap A.P., Doran E., Gillespie J.P., and O'Toole A. Mitochondria and cell death. Biochemical Society Transactions 28 2 (2000) 170-177
36. Han O.J., Joe K.H., Kim S.W., Lee H.S., Kwon N.S., Baek K.J., and Yun H.Y. Involvement of p38 mitogen-activated protein kinase and apoptosis signal-regulating kinase-1 in nitric oxide-induced cell death in PC12 cells. Neurochemical Research 26 5 (2001) 525-532
37. Harada N., Miura T., Dairaku Y., Kametani R., Shibuya M., Wang R., Kawamura S., and Matsuzaki M. NO donor-activated PKC-delta plays a pivotal role in ischemic myocardial protection through accelerated opening of mitochondrial K-ATP channels. Journal of Cardiovascular Pharmacology 44 1 (2004) 35-41
38. Hare J.M. Nitric oxide and extitation-contraction coupling. Journal of Molecular and Cellular Cardiology 35 7 (2003) 719-729
39. Hare J.M., and Colucci W.S. Role of nitric oxide in the regulation of myocardial function. Progress in Cardiovascular Diseases 38 2 (1995) 155-166
40. Hartman J.C. The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Annals of Thoracic Surgery 60 3 (1995) 789-792
41. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends in Cardiovascular Medicine 15 2 (2005) 69-75
42. Heymes C., Vanderheyden M., Bronzwaer J.G., Shah A.M., and Paulus W.J. Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy. Circulation 99 23 (1999) 3009-3016
43. Hobbs A.J., Fukuto J.M., and Ignarro L.J. Formation of free nitric oxide from l-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase. Proceedings of the National Academy of Sciences of the United States of America 91 23 (1994) 10992-10996
44. Ikeda U., Kurosaki K., Ohya K., and Shimada K. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells. Cardiovascular Research 35 1 (1997) 168-174
45. Ikeda U., Kurosaki K., Shimpo M., Okada K., Saito T., and Shimada K. Adenosine stimulates nitric oxide synthesis in rat cardiac myocytes. American Journal of Physiology 273 1 Pt 2 (1997) H59-H65
46. Ishibashi Y., Mizrahi J., Duncker D.J., and Bache R.J. The nitric oxide donor ITF 1129 augments subendocardial blood flow during exercise-induced myocardial ischemia. Journal Cardiovascular Pharmacology 30 3 (1997) 374-382
47. Javadov S.A., Clarke S., Das M., Griffiths E.J., Lim K.H., and Halestrap A.P. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. Journal of Physiology 549 Pt 2 (2003) 513-524
48. Johnson III G., Tsao P.S., Mulloy D., and Lefer A.M. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. Journal of Pharmacology and Experimental Therapeutics 252 1 (1990) 35-41
49. Kalkman E.A., van Haren P., Saxena P.R., and Schoemaker R.G. Regionally different vascular response to vasoactive substances in the remodelled infarcted rat heart; aberrant vasculature in the infarct scar. Journal of Molecular and Cellular Cardiology 29 5 (1997) 1487-1497
50. Kanai A.J., Mesaros S., Finkel M.S., Oddis C.V., Birder L.A., and Malinski T. Beta-adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. American Journal of Physiology 273 4 Pt 1 (1997) C1371-C1377
51. Katori T., Hoover D.B., Ardell J.L., Helm R.H., Belardi D.F., Tocchetti C.G., Forfia P.R., Kass D.A., and Paolocci N. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Circulation Research 96 2 (2005) 234-243
52. Katusic Z.S., and Vanhoutte P.M. Superoxide anion is an endothelium-derived contracting factor. American Journal of Physiology 257 1 Pt 2 (1989) H33-H37
53. Khan S.A., Skaf M.W., Harrison R.W., Lee K., Minhas K.M., Kumar A., Fradley M., Shoukas A.A., Berkowitz D.E., and Hare J.M. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circulation Research 92 12 (2003) 1322-1329
54. Kitade H., Sakitani K., Inoue K., Masu Y., Kawada N., Hiramatsu Y., Kamiyama Y., Okumura T., and Ito S. Interleukin 1 beta markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 23 4 (1996) 797-802
55. Kojda G. Mechanisms of inotropic effects induced by nitric oxide. Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 2 Suppl 3 (2001) 48S-49S
56. Kojda G., and Kottenberg K. Regulation of basal myocardial function by NO. Cardiovascular Research 41 3 (1999) 514-523
57. Kojda G., Kottenberg K., Nix P., Schluter K.D., Piper H.M., and Noack E. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circulation Research 78 1 (1996) 91-101
58. Kojda G., Laursen J.B., Ramasamy S., Kent J.D., Kurz S., Burchfield J., Shesely E.G., and Harrison D.G. Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovascular Research 42 1 (1999) 206-213
59. Layland J., Li J.M., and Shah A.M. Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes. Journal of Physiology 540 Pt 2 (2002) 457-467
60. Le Corvoisier P., Lopes M.E., Su J., and Hittinger L. Role du monoxyde d'azote dans l'insuffisance cardiaque. Journal de la Societe de Biologie 194 3-4 (2000) 143-149
61. Liu Y.H., Yang X.P., Sharov V.G., Sigmon D.H., Sabbath H.N., and Carretero O.A. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 27 1 (1996) 7-13
62. Liu Y.H., Xu J., Yang X.P., Yang F., Shesely E., and Carretero O.A. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure. Hypertension 39 2 Pt 2 (2002) 375-381
63. Liu J.Q., Sham J.S., Shimoda L.A., Kuppusamy P., and Sylvester J.T. Hypoxic constriction and reactive oxygen species in porcine distal pulmonary arteries. American Journal of Physiology. Lung Cellular and Molecular Physiology 285 2 (2003) L322-L333
64. Martin S.R., Emanuel K., Sears C.E., Zhang Y.H., and Casadei B. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovascular Research 70 1 (2006) 97-106
65. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., and Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 4 (2000) 365-376
66. Massion P.B., and Balligand J.L. Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. Journal of Physiology 546 Pt 1 (2003) 63-75
67. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., and Ignarro L.J. Role of l-arginine-nitric oxide pathway in myocardial reoxygenation injury. American Journal of Physiology 262 2 Pt 2 (1992) H616-H620
68. Matter C.M., Mandinov L., Kaufmann P.A., Vassalli G., Jiang Z., and Hess O.M. Effect of NO donors on LV diastolic function in patients with severe pressure-overload hypertrophy. Circulation 99 18 (1999) 2396-2401
69. Minc-Golomb D., and Schwartz J.P. Expression of both constitutive and inducible nitric oxide synthases in neuronal and astrocyte cultures. Annals of the New York Academy of Sciences 738 (1994) 462-467
70. Miranda K.M., Yamada K., Espey M.G., Thomas D.D., DeGraff W., Mitchell J.B., Krishna M.C., Colton C.A., and Wink D.A. Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angeli's salt and synthetic peroxynitrite. Archives of Biochemistry and Biophysics 401 2 (2002) 134-144
71. Mohan P., Brutsaert D.L., Paulus W.J., and Sys S.U. Myocardial contractile response to nitric oxide and cGMP. Circulation 93 6 (1996) 1223-1229
72. Mugge A., Lopez J.A., Piegors D.J., Breese K.R., and Heistad D.D. Acetylcholine-induced vasodilatation in rabbit hindlimb in vivo is not inhibited by analogues of l-arginine. American Journal of Physiology 260 1 Pt 2 (1991) H242-H247
73. Muller-Strahl G., Kottenberg K., Zimmer H.G., Noack E., and Kojda G. Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart. Journal of Physiology 522 Pt 2 (2000) 311-320
74. Nebigil C., and Malik K.U. Alpha adrenergic receptor subtypes involved in prostaglandin synthesis are coupled to Ca++ channels through a pertussis toxin-sensitive guanine nucleotide-binding protein. Journal of Pharmacology and Experimental Therapeutics 266 2 (1993) 1113-1124
75. Obata T. Adenosine production and its interaction with protection of ischemic and reperfusion injury of the myocardium. Life Sciences 71 18 (2002) 2083-2103
76. Ostrea E.M., Villanueva-Uy E.T., Natarajan G., and Uy H.G. Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management. Paediatric Drugs 8 3 (2006) 179-188
77. Pacher P., Beckman J.S., and Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiological Reviews 87 1 (2007) 315-424
78. Pagliaro P., Dalla Valle R., Gattullo D., Merletti A., and Marsh N.A. The heart rate after inhibition of nitric oxide release in the anaesthetized dog. General Pharmacology 27 4 (1996) 695-699
79. Pagliaro P., Gattullo D., Rastaldo R., and Losano G. Ischemic preconditioning: from the first to the second window of protection. Life Sciences 69 1 (2001) 1-15
80. Pagliaro P., Mancardi D., Rastaldo R., Penna C., Gattullo D., Miranda K.M., Feelisch M., Wink D.A., Kass D.A., and Paolocci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radical Biology & Medicine 34 1 (2003) 33-43
81. Paolocci N., Saavedra W.F., Miranda K.M., Martignani C., Isoda T., Hare J.M., Espey M.G., Fukuto J.M., Feelisch M., Wink D.A., and Kass D.A. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proceedings of the National Academy of Sciences of the United States of America 98 18 (2001) 10463-10468
82. Paolocci N., Katori T., Champion H.C., St John M.E., Miranda K.M., Fukuto J.M., Wink D.A., and Kass D.A. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from beta-adrenergic signaling. Proceedings of the National Academy of Sciences of the United States of America 100 9 (2003) 5537-5542
83. Patel V.C., Yellon D.M., Singh K.J., Neild G.H., and Woolfson R.G. Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochemical and Biophysical Research Communications 194 1 (1993) 234-238
84. Paulus W.J. Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'. Heart Failure Reviews 5 4 (2000) 337-344
85. Paulus W.J. The role of nitric oxide in the failing heart. Heart Failure Reviews 6 2 (2001) 105-118
86. Paulus W.J., and Bronzwaer J.G. Nitric oxide's role in the heart: control of beating or breathing?[see comment]. American Journal of Physiology. Heart and Circulatory Physiology 287 1 (2004) H8-H13
87. Paulus W.J., Vantrimpont P.J., and Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89 5 (1994) 2070-2078
88. Paulus W.J., Frantz S., and Kelly R.A. Nitric oxide and cardiac contractility in human heart failure: time for reappraisal. Circulation 104 19 (2001) 2260-2262
89. Pearson P.J., and Vanhoutte P.M. Vasodilator and vasoconstrictor substances produced by the endothelium. Reviews of Physiology, Biochemistry and Pharmacology 122 (1993) 1-67
90. Pearson P.J., Lin P.J., and Schaff H.V. Production of endothelium-derived contracting factor is enhanced after coronary reperfusion. Annals of Thoracic Surgery 51 5 (1991) 788-793
91. Pelat M., Massion P.B., and Balligand J.L. Nitric oxide "at heart": emerging paradigms after a decade. Archives des Maladies du Coeur et des Vaisseaux 98 3 (2005) 242-248
92. Penna C., Pagliaro P., Rastaldo R., Mancardi D., Cappello C., Gattullo D., and Losano G. Coronary vasculature in ischemic preconditioning. Recent Research Developent in Life Sciences 1 1 (2003) 13-26
93. Penna C., Cappello S., Mancardi D., Raimondo S., Rastaldo R., Gattullo D., Losano G., and Pagliaro P. Post-conditioning reduces infarct size in the isolated rat heart: role of coronary flow and pressure and the nitric oxide/cGMP pathway. Basic Research in Cardiology 101 2 (2006) 168-179
94. G-hydroxy-l-arginine by nitric oxide synthase. Biochemistry 34 6 (1995) 1930-1941
95. Ray C.J., and Marshall J.M. Measurement of nitric oxide release evoked by systemic hypoxia and adenosine from rat skeletal muscle in vivo. Journal of Physiology 568 Pt 3 (2005) 967-978
96. Ray C.J., and Marshall J.M. The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium. Journal of Physiology 570 Pt 1 (2006) 85-96
97. Recchia F.A., McConnell P.I., Bernstein R.D., Vogel T.R., Xu X., and Hintze T.H. Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog.[see comment]. Circulation Research 83 10 (1998) 969-979
98. Recchia F.A., McConnell P.I., Loke K.E., Xu X., Ochoa M., and Hintze T.H. Nitric oxide controls cardiac substrate utilization in the conscious dog. Cardiovascular Research 44 2 (1999) 325-332
99. Rusche K.M., Spiering M.M., and Marletta M.A. Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase. Biochemistry 37 44 (1998) 15503-15512
100. Saavedra W.F., Paolocci N., St John M.E., Skaf M.W., Stewart G.C., Xie J.S., Harrison R.W., Zeichner J., Mudrick D., Marban E., Kass D.A., and Hare J.M. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circulation Research 90 3 (2002) 297-304
101. Saraiva R.M., and Hare J.M. Nitric oxide signaling in the cardiovascular system: implications for heart failure. Current Opinions in Cardiology 21 3 (2006) 221-228
102. Sasaki N., Sato T., Ohler A., O'Rourke B., and Marban E. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation 101 4 (2000) 439-445
103. Sato T., O'Rourke B., and Marban E. Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circulation Research 83 1 (1998) 110-114
104. Scherrer-Crosbie M., Ullrich R., Bloch K.D., Nakajima H., Nasseri B., Aretz H.T., Lindsey M.L., Vancon A.C., Huang P.L., Lee R.T., Zapol W.M., and Picard M.H. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation 104 11 (2001) 1286-1291
105. Schini V.B., and Vanhoutte P.M. Endothelin-1: a potent vasoactive peptide. Pharmacology & Toxicology 69 5 (1991) 303-309
106. Schmidt H.H., Hofmann H., Schindler U., Shutenko Z.S., Cunningham D.D., and Feelisch M. No .NO from NO synthase. Proceedings of the National Academy of Sciences of the United States of America 93 25 (1996) 14492-14497
107. Schulz R., Kelm M., and Heusch G. Nitric oxide in myocardial ischemia/reperfusion injury. Cardiovascular Research 61 3 (2004) 402-413
108. Sears C.E., Bryant S.M., Ashley E.A., Lygate C.A., Rakovic S., Wallis H.L., Neubauer S., Terrar D.A., and Casadei B. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circulation Research 92 5 (2003) e52-e59
109. Sears C.E., Ashley E.A., and Casadei B. Nitric oxide control of cardiac function: is neuronal nitric oxide synthase a key component?. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 359 1446 (2004) 1021-1044
110. Senzaki H., Smith C.J., Juang G.J., Isoda T., Mayer S.P., Ohler A., Paolocci N., Tomaselli G.F., Hare J.M., and Kass D.A. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB Journal 15 10 (2001) 1718-1726
111. Setty S., Tune J.D., and Downey H.F. Nitric oxide contributes to oxygen demand-supply balance in hypoperfused right ventricle. Cardiovascular Research 64 3 (2004) 431-436
112. Shah A.M., and MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacology & Therapeutics 86 1 (2000) 49-86
113. Shen W., Hintze T.H., and Wolin M.S. Nitric oxide. An important signaling mechanism between vascular endothelium and parenchymal cells in the regulation of oxygen consumption. Circulation 92 12 (1995) 3505-3512
114. Shinke T., Takaoka H., Takeuchi M., Hata K., Kawai H., Okubo H., Kijima Y., Murata T., and Yokoyama M. [Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy]. Journal of Cardiology 37 2 (2001) 119-120
115. Sovershaev M.A., Egorina E.M., Andreasen T.V., Jonassen A.K., and Ytrehus K. Preconditioning by 17beta-estradiol in isolated rat heart depends on PI3-K/PKB pathway, PKC, and ROS. American Journal of Physiology. Heart and Circulatory Physiology 291 4 (2006) H1554-H1562
116. Suenobu N., Shichiri M., Iwashina M., Marumo F., and Hirata Y. Natriuretic peptides and nitric oxide induce endothelial apoptosis via a cGMP-dependent mechanism. Arteriosclerosis, Thrombosis and Vascular Biology 19 1 (1999) 140-146
117. Taimor G., Hofstaetter B., and Piper H.M. Apoptosis induction by nitric oxide in adult cardiomyocytes via cGMP-signaling and its impairment after simulated ischemia. Cardiovascular Research 45 3 (2000) 588-594
118. Taimor G., Rakow A., and Piper H.M. Transcription activator protein 1 (AP-1) mediates NO-induced apoptosis of adult cardiomyocytes. FASEB Journal 15 13 (2001) 2518-2520
119. Tang K.M., Wang G.R., Lu P., Karas R.H., Aronovitz M., Heximer S.P., Kaltenbronn K.M., Blumer K.J., Siderovski D.P., Zhu Y., and Mendelsohn M.E. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nature Medicine 9 12 (2003) 1506-1512
120. Tavernier B., Mebazaa A., Mateo P., Sys S., Ventura-Clapier R., and Veksler V. Phosphorylation-dependent alteration in myofilament Ca2+ sensitivity but normal mitochondrial function in septic heart. American Journal of Respiratory and Critical Care Medicine 163 2 (2001) 362-367
121. Tiravanti E., Samouilov A., and Zweier J.L. Nitrosyl-heme complexes are formed in the ischemic heart: evidence of nitrite-derived nitric oxide formation, storage, and signaling in post-ischemic tissues. Journal of Biological Chemistry 279 12 (2004) 11065-11073
122. Traverse J.H., Chen Y., Hou M., and Bache R.J. Inhibition of NO production increases myocardial blood flow and oxygen consumption in congestive heart failure. American Journal of Physiology. Heart and Circulatory Physiology 282 6 (2002) H2278-H2283
123. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circulation Research 95 3 (2004) 230-232
124. Tsang A., Hausenloy D.J., and Yellon D.M. Myocardial postconditioning: reperfusion injury revisited. American Journal of Physiology. Heart and Circulatory Physiology 289 1 (2005) H2-H7
125. Vegh A., Szekeres L., and Parratt J. Preconditioning of the ischaemic myocardium; involvement of the l-arginine nitric oxide pathway. British Journal of Pharmacology 107 3 (1992) 648-652
126. Vegh A., Papp J.G., Szekeres L., and Parratt J.R. Prevention by an inhibitor of the l-arginine-nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs. British Journal of Pharmacology 110 1 (1993) 18-19
127. Vila-Petroff M.G., Younes A., Egan J., Lakatta E.G., and Sollott S.J. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circulation Research 84 9 (1999) 1020-1031
128. Wang Y., Hirai K., and Ashraf M. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity. Circulation Research 85 8 (1999) 731-741
129. Wang Y., Wagner M.B., Joyner R.W., and Kumar R. cGMP-dependent protein kinase mediates stimulation of L-type calcium current by cGMP in rabbit atrial cells. Cardiovascular Research 48 2 (2000) 310-322
130. Wang G., Liem D.A., Vondriska T.M., Honda H.M., Korge P., Pantaleon D.M., Qiao X., Wang Y., Weiss J.N., and Ping P. Nitric oxide donors protect murine myocardium against infarction via modulation of mitochondrial permeability transition. American Journal of Physiology. Heart and Circulatory Physiology 288 3 (2005) H1290-H1295
131. Ward J.E., and Angus J.A. Acute and chronic inhibition of nitric oxide synthase in conscious rabbits: role of nitric oxide in the control of vascular tone. Journal of Cardiovascular Pharmacology 21 5 (1993) 804-814
132. Westerhof N. Nitric oxide and efficiency of the right heart.[comment]. Cardiovascular Research 64 3 (2004) 379-380
133. Willmott N., Sethi J.K., Walseth T.F., Lee H.C., White A.M., and Galione A. Nitric oxide-induced mobilization of intracellular calcium via the cyclic ADP-ribose signaling pathway. Journal of Biological Chemistry 271 7 (1996) 3699-3705
134. Wynne A.M., Mocanu M.M., and Yellon D.M. Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK. Journal of Cardiovascular Pharmacology 46 6 (2005) 817-822
135. Xie Y.W., Shen W., Zhao G., Xu X., Wolin M.S., and Hintze T.H. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circulation Research 79 3 (1996) 381-387
136. Xu L., Eu J.P., Meissner G., and Stamler J.S. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279 5348 (1998) 234-237
137. Xu K.Y., Huso D.L., Dawson T.M., Bredt D.S., and Becker L.C. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 96 2 (1999) 657-662
138. Xu K.Y., Kuppusamy S.P., Wang J.Q., Li H., Cui H., Dawson T.M., Huang P.L., Burnett A.L., Kuppusamy P., and Becker L.C. Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation. Journal of Biological Chemistry 278 43 (2003) 41798-41803
139. Xuan Y.T., Guo Y., Han H., Zhu Y., and Bolli R. An essential role of the JAK-STAT pathway in ischemic preconditioning. Proceedings of the National Academy of Sciences of the United States of America 98 16 (2001) 9050-9055
140. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332 6163 (1988) 411-415
141. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiological Reviews 83 4 (2003) 1113-1151
142. -/- mice. Circulation 112 17 (2005) II-308
143. Zhu B., Sun Y., Sievers R.E., Shuman J.L., Glantz S.A., Chatterjee K., Parmley W.W., and Wolfe C.L. l-arginine decreases infarct size in rats exposed to environmental tobacco smoke. American Heart Journal 132 1 Pt 1 (1996) 91-100